European Journal of Neurology

Article	Citations
Issue Information	270
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	134
Comorbidity patterns in people with multiple sclerosis: A latent class analysis of the Australian Multiple Sclerosis Longitudinal Study	129
COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition	101
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study	91
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosis	91
Lessons from the past to understand the future	90
	87
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	86
The effect of influenza vaccination on the rate of dementia amongst older adults	84
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	84
The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency	82
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	80
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	78
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	65
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	65
Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors	60
Central nervous system crystal‐storing histiocytosis: A case report and literature review	56
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	56
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	55
Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	55
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	54
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	54
Prioritization process for European Academy of Neurology clinical practice guidelines	53
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	53

Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	52
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	51
Risk factors, neuroimaging correlates and prognosis of the motoric cognitive risk syndrome: A population‐based comparison with mild cognitive impairment	48
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	46
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	45
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	45
Mirror therapy for unilateral neglect after stroke: A systematic review	45
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	44
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	43
Comparative features and outcomes of major neurological complications of COVID‐19	42
Immunity and Gilles de la Tourette syndrome: A systematic review and meta‐analysis of evidence for immune implications in Tourette syndrome	41
Out‐of‐hospital versus in‐hospital status epilepticus: The role of etiology and comorbidities	41
Long‐term MRI changes in a patient with Kelch‐like protein 11‐associated paraneoplastic neurological syndrome	40
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms	40
Plasma neurofilament light chain levels predict improvement in late phase after stroke	39
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	39
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	38
	38
Oral Presentations	38
Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients	38
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	38
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	37
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	37
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	37
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	37
	36
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	36
Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study	36
Issue Information	36
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	35
Issue Information	35
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	35
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	34
The characteristics of intracranial plaques of unilateral, anterior circulation embolic stroke of undetermined source: An analysis of different subtypes based on high‐resolution imaging	34
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	34
Focused Workshops	34
Issue Information	34
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	33
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	32
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	32
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	32
Clinical manifestations and long‐term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Eu	32
Social cognition deficits in amyotrophic lateral sclerosis: A pilot cross‐sectional population‐based study	31
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	31
Neurology Undergraduate Medical Education: A Scoping Review	31
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	30
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	30
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	30
First‐line steroid treatment for spontaneous intracranial hypotension	30
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	30

Macroglossia: A potentially severe complication of late‐onset Pompe disease	29
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	29
Ipsilateral hand impairment predicts long‐term outcome in patients with subacute stroke	29
A multimodal, longitudinal study of cognitive heterogeneity in early‐onset Alzheimer's disease	28
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	28
Dynamic Bayesian networks for stratification of disease progression in amyotrophic lateral sclerosis	28
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	28
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	28
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	28
Association of symptomatic atherosclerotic carotid arteries with plaque areas showing low densities on computed tomographic angiography	28
Issue Information	28
Generative artificial intelligence in neurology: Opportunities and risks	28
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	27
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis	27
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	27
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	27
Risk and outcomes of COVID‐19 in patients with multiple sclerosis	27
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	27
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	27
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	26
Care in Europe after presenting to the emergency department with a seizure; position paper and insights from the European Audit of Seizure Management in Hospitals	26
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	26
ePresentations	26
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	26
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	26
Symposia	26
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	26
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	25
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	25
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	25
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	25
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	25
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	24
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	24
Issue Information	24
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	24
Latency of poststroke epilepsy can predict drug resistance	24
Rheumatoid meningitis: A systematic review and meta‐analysis	24
Use of antihypertensive medication and formation of de novo intracranial aneurysms	24
Association between choroid plexus volume and cognition in Parkinson disease	23
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	23
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	23
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	23
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	23
Intracranial aneurysm wall enhancement as an indicator of instability: a systematic review and meta‐analysis	23
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	23
Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation	23
The many faces of globular glial tauopathy: A clinical and imaging study	22
Hormone therapy and disease activity in Danish women with multiple sclerosis: A population‐based cohort study	22
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	22
Clinical presentation and neural correlates of stroke‐associated spatial delusions	22
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	22
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	22
The core/penumbra model: implications for acute stroke treatment and patient selection in 2021	22
The spectrum of central nervous system involvement in Whipple's disease	22
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	22
Non‐alcoholic fatty liver disease and stroke: A Mendelian randomization study	22
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	22
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	22
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	22
Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	21
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	21
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	21
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	21
Double immune reconstitution therapy: Cladribine after alemtuzumab in the treatment of multiple sclerosis	21
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	21
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	21
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	21
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	21
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	21
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	21
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	21
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	20
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	20
Circulating choline pathway nutrients and depression after ischemic stroke	20
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	20
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	20
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	20
Epilepsy Management in Transgender Population: More Research for Better Treatment	20
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	20

Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	20
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	20
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials	20
Plenary Sessions	20
Migraine and atrial fibrillation: a systematic review	20
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	20
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	19
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	19
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	19
Special Sessions	19
Lower cerebral arterial blood flow is associated with greater serum neurofilament light chain levels in multiple sclerosis patients	19
Hospital readmissions following infections in dementia: a nationwide and registry‐based cohort study	19
Dolichoarteriopathies of the extracranial internal carotid artery: The Plaque At RISK study	19
Cognitive sequelae of long COVID may not be permanent: A prospective study	19
Corrigendum	19
Younger adults and endovascular thrombectomy	19
Bruns' nystagmus revisited: A sign of stroke in patients with the acute vestibular syndrome	19
Confirmed disability progression as a marker of permanent disability in multiple sclerosis	19
Antidepressant use and stroke or mortality risk in the elderly	19
Efficiency of stroke networks for referral of mechanical thrombectomy: The more the better?	19
Corrigendum	19
Response to the Letter to the Editor by Arshad and Bronstein “Motion perception in vestibular migraine”	19
The effect of head‐down tilt in experimental acute ischemic stroke	18
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	18
Special Sessions	18
The Attitude towards Polypills Questionnaire (APPQ): a phase I–III development and validation study in patients with cerebrovascular disease	18
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	18
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	18
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	18
Giancarlo COMI (1947–2024)	18
Issue Information	18
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	18
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	18
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	18
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	18
Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study	18
Polygenic risk of Alzheimer's disease in the Faroe Islands	18
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	18
Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis	18
Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID‐19	17
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	17
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	17
Parkinson disease following COVID‐19: Report of six cases	17
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	17
The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)	17
European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases	17
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	17
Quantitative magnetic resonance neurographic characterization of peripheral nerve involvement in manifest and pre‐ataxic spinocerebellar ataxia type 3	17
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	17
Sex differences in early‐onset Alzheimer's disease	17
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	17
Behavioural intervention in medication overuse headache: A concealed double‐blind randomized controlled trial	17
Admission computed tomography radiomic signatures outperform hematoma volume in predicting baseline clinical severity and functional outcome in the ATACH‐2 trial intracerebral hemorrhage population	17
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	17
Early infantile epileptic encephalopathy related to NECAP1: Clinical delineation of the disease and review	17
Association of short‐term exposure to ambient air pollution with mortality from ischemic and hemorrhagic stroke	17
Clinical autonomic nervous system laboratories in Europe	17
The analgesic effect of electroencephalographic neurofeedback for people with chronic pain: A systematic review and meta‐analysis	17
Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts	17
Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel	17
Early predictors of dysphagia in ischaemic stroke patients	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	16
	16
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	16
Response to the Letter to the Editor in response to “Hepatitis E virus and Bell’s palsy”	16
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis	16
Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines	16
	16
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	16
Topical Symposia	16
	16
The first European Academy of Neurology (EAN) Science School: shaping the next generation of translational neurologists	16
	16
The 20th anniversary of the first clinical use of Stalevo®	16
Corrigendum	16
Upper motor neuron dysfunction is associated with the presence of behavioural impairment in patients with amyotrophic lateral sclerosis	16
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis	16
Shoulder‐Touch test to reveal incongruencies in persons with functional motor disorders	16
Plenary Sessions	16
GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration	16
	16
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	16
Focused Workshops	16
Dementia among international migrants: An urgent call for better care	16
Symposia	16
Psychogenic non‐epileptic seizure‐status in patients admitted to the intensive care unit	15
Telemedicine for neurological diseases: A systematic review and meta‐analysis	15
Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia: A 3‐year follow‐up	15
Central nervous system cavernous malformations: cross‐sectional study assessing rebleeding risk after a second haemorrhage	15
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study	15
Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: A critical systematic review	15
Chronic vestibular syndromes in the elderly: Presbyvestibulopathy—an isolated clinical entity?	15